Last update Oct. 12, 2022
Incompatible
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
Benfluorex Hydrochloride in other languages or writings:
Benfluorex Hydrochloride belongs to these groups or families:
Write us at elactancia.org@gmail.com
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2015 of United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
It is an anorectic and hypolipidemic agent structurally related to fenfluramine. Oral administration three times a day.
Since the last update we have not found published data on its excretion in breastmilk.
Due to frequent and serious cardiovascular side effects (Laurent 2022, McGee 2018, Eugène 2018, Melloul 2015, Fournier 2012), the European Medicines Agency recommended withdrawing benfluorex in 2009. (EMA 2010)
There is good quality evidence that exclusive breastfeeding helps to regain pre-pregnancy weight earlier than if breastfeeding is partial (mixed) or there is no breastfeeding, and that prolonged breastfeeding helps maintain that loss and as well as body fat loss.(Jayasinghe 2021, Schalla 2017, López 2016, Jarlenski 2014, Sámano 2013, Neville 2014, Hatsu 2008, Dewey 2004, 2001 y 1993, Kramer 1993)